Skip to content

John Paul Aboubechara, MD, PHD

NPI 1205461803ActiveIndividual· Psychiatry & Neurology, Neurology· Palo Alto, CA

Psychiatry & Neurology, Neurology (MD, PHD) in Palo Alto, California, licensed in CA, with an NPI issued in March 2020. Part D covered 71 prescriptions written in 2024, 93% of them generic. Argenx US, Inc. reported $125.00 in payments in 2025, mostly food and beverage.

Overview

NPI1205461803
StatusActive
Entity typeIndividual
CredentialMD, PHD
Sole proprietorNo
NPI issuedMar 4, 2020
Last updated in NPPESJun 14, 2026
Certified by providerJun 14, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Psychiatry & Neurology, Neurology Primary2084N0400XA191588CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Neurology (CA)

Part D prescriptions in 2024

Prescriptions (claims)71 · 128 30-day fills
Patients20
Total drug cost$3,782
Generic share93% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$125.00 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Argenx US, Inc.$125.001

What the 2025 payments were for

  • Food and Beverage$125.00 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Psychiatry & Neurology, Neurology providers in Palo Alto

All Psychiatry & Neurology, Neurology providers in California →